Xtandi® A New Standard Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer?

CancerConnect News Results from the Phase 3 PROSPER clinical trial in patients with non-metastatic Castration-Resistant Prostate Cancer CRPC were released this week at the 2018 Genitourinary Cancers Symposium in San Francisco and demonstrate that the use [...]

Diagnosed with Colon Cancer: 10 Tips on How to Get The Most From Your Doctor

1 Choose Your Doctor Carefully Medical oncologists are the primary doctors involved with colon cancer and work in collaboration with surgeons and gastroenterologists Pick a medical oncologist carefully rely on people you trust including nurses and other h [...]

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

A clinically relevant liquid biopsy test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer TNBC according to new research published by a multi-institutional team of re [...]

Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer

CancerConnect News Treatment with Cabometyx cabozantinib significantly improved outcomes in patients with advanced hepatocellular carcinoma HCC leading researchers to suggest that it could offer a new treatment option for this patient population The new f [...]

Erleada is The First Treatment for Non-metastatic Castration-resistant Prostate Cancer

CancerConnect News Men who are being treated with androgen deprivation therapy ADT and see their prostate specific antigen PSA levels begin to increase have a new treatment option The US Food and Drug Administration FDA has approved Erleada Apalutamide fo [...]

Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer

CancerConnect News According to the results of a study presented at the recent gastrointestinal cancer symposia Keytruda pembrolizumab is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar sorafenib1 About [...]

Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation

Myriad Genetics a leader in molecular diagnostics and personalized medicine announced today that results from a large 1162 patient study will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco Calif The [...]

Keytruda Promising in PD-L1 Esophageal Cancer

CancerConnect News The checkpoint inhibitor Keytruda pembrolizumab has been reported to produce an overall response rate of 30 in patients with PD-L1positive advanced esophageal cancer1 About Keytruda Keytruda is a monoclonal antibody that helps to restor [...]

Kisqali Combination Promising for Pre-menopausal Hormone Receptor Positive Breast Cancer

CancerConnect News The CDK46 inhibitor Kisqali ribociclib has been given breakthrough status by the US Food and Drug Administration as an initial endocrine-based treatment for of pre- or perimenopausal women with hormone-receptor positive human epidermal [...]

Five Common Sign & Symptoms of Breast Cancer

CancerConnect News Breast cancer is a cancer that originates in the area of the breast where cells replicate too quickly causing a tumor Breast cancer is most common in women but I can also occur in men Breast cancer is caused by an abnormality that is ge [...]